Market-based payment policies such as competitive bidding, reference pricing, centers of excellence and tiered provider networks have been implemented both in Medicare and across the private sector, as described in this report required by Executive Order 13890.
Medicare
Reports
Displaying 41 - 50 of 184. 10 per page. Page 5.
Advanced SearchMedicare FFS Part B and International Drug Prices: A Comparison of the Top 50 Drugs
The September 13, 2020 Executive Order on Lowering Drug Prices by Putting America First declared, “It is the policy of the United States that the Medicare program should not pay more for costly Part B or Part D prescription drugs or biological products than the most-favored-nation price.” The Most Favored Nation (MFN) Model issued by the Centers for Medicare & Medicaid Services (CMS) on No
Changes in Home Health Care Use in Medicare Advantage Compared to Traditional Medicare, 2011-2016
CHANGES IN HOME HEALTH CARE USE IN MEDICARE ADVANTAGE COMPARED TO TRADITIONAL MEDICARE, 2011-2016
Stephen Zuckerman, Laura Skopec, Joshua Aarons, Robert A. Berenson, Judith Feder, and Douglas Wissoker
Urban Institute
Peter J. Huckfeldt
Research Brief
Advance Care Planning Among Medicare Fee-For-Service Beneficiaries and Practitioners: Research Brief
Advance Care Planning Among Medicare Fee-For-Service Beneficiaries and Practitioners: Research Brief Fang He, PhD; Angela Gasdaska, BS; Hannah Friedman, BA; Brendan Wedehase, BS; Alexis Kirk, PhD; Ila Broyles, PhD; Sarita L.
ADVANCE CARE PLANNING AMONG MEDICARE FEE-FOR-SERVICE BENEFICIARIES AND PRACTITIONERS: FINAL REPORT
ADVANCE CARE PLANNING AMONG MEDICARE FEE-FOR-SERVICE BENEFICIARIES AND PRACTITIONERS: FINAL REPORT Fang He, PhD, Angela Gasdaska, BS, Hannah Friedman, BA, Brendan Wedehas, BS, Alexis Kirk, PhD, Ila Broyles, PhD, and SaritaL.
ASPE Issue Brief
The Impact of COVID-19 on Medicare Health Services and Payments
Beginning in mid-March 2020, the COVID-19 pandemic has had an unprecedented impact on health care utilization. The impact on patients, their families and the health care system was significant.
Report to Congress
Second Report to Congress on Social Risk and Medicare's Value-Based Purchasing Programs
As required by the IMPACT Act, the second Report to Congress examines the effect of individuals’ social risk factors on quality measures, resource use, and other measures under the Medicare program, as well as analyses of the effects of Medicare’s current value-based payment programs on providers serving socially at-risk beneficiaries and simulations of potential policy options to address these
Support And Services at Home (SASH) Evaluation: SASH Evaluation Findings, 2010-2016
This document provides highlights of the evaluation of the Support and Services at Home (SASH) program for the first years of the program (2010-2016). The SASH program in Vermont is a promising approach to providing support services and care coordination to older adults and individuals with disabilities, using affordable housing properties as a platform for service delivery.
ASPE Issue Brief
Assessing the Costs and Benefits of Extending Coverage of Immunosuppressive Drugs under Medicare
By statute, the majority of patients with end-stage renal disease (ESRD) are eligible for Medicare, regardless of age. Kidney transplantation is ultimately considered the best treatment for ESRD, but ESRD-related eligibility for Medicare coverage extends for only 36 months post-transplant.
ASPE Issue Brief
The Special Diabetes Program for Indians: Estimates of Medicare Savings
Between 1996 and 2013, there was a 54% decrease in the incidence of diabetes-related end-stage renal disease (ESRD-DM) in American Indian and Alaska Native (AI/ AN) populations. This decline has occurred since the Special Diabetes Program for Indians (SDPI) was established in 1997.